May 26, 2022 / 08:30PM GMT
Operator
Good day, and thank you for standing by, and welcome to the Kane Biotech Q1 2022 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded. (Operator Instructions)
I would now like to hand the conference over to your host today, Nicole Sendey, Kane Biotech Investor Relations and Public Relations Specialist. You may begin.
Nicole Sendey - Kane Biotech Inc - Director, IR & Public Relations
Thank you. Good afternoon, and welcome, everyone, to Kane Biotech's quarterly earnings conference call. We are delighted to have you join us today. This call will cover Kane's financial and operating results for the first quarter of 2022 along with a discussion of some of our recent highlights and goals for 2022 and beyond. Following our prepared remarks, we will open the conference call to a question-and-answer session. Our call today will be led by Kane's Chief Executive Officer, Marc Edwards.
Before we begin our formal remarks, I would like to remind everyone that some of the statements on this
Q1 2022 Kane Biotech Inc Earnings Call Transcript
May 27, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers